Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Director Sells $103,000.00 in Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) Director David Pelizzon sold 4,000 shares of OrthoPediatrics stock in a transaction on Monday, August 24th. The shares were sold at an average price of $25.75, for a total value of $103,000.00. Following the completion of the transaction, the director owned 6,897,764 shares of the company’s stock, valued at approximately $177,617,423. This trade represents a 0.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

OrthoPediatrics Trading Up 1.4%

KIDS opened at $23.65 on Friday. The business has a fifty day moving average price of $21.41 and a 200 day moving average price of $18.66. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17. OrthoPediatrics Corp. has a 12 month low of $14.42 and a 12 month high of $26.74. The stock has a market capitalization of $617.50 million, a price-to-earnings ratio of -14.08 and a beta of 0.98.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The company had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. Sell-side analysts expect that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the stock. AIGH Capital Management LLC purchased a new stake in OrthoPediatrics in the second quarter valued at $5,161,000. Wasatch Advisors LP boosted its stake in OrthoPediatrics by 56.6% in the second quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock valued at $9,865,000 after acquiring an additional 186,357 shares in the last quarter. Roubaix Capital LLC grew its holdings in shares of OrthoPediatrics by 23.8% during the first quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock worth $4,603,000 after purchasing an additional 55,724 shares during the last quarter. Granahan Investment Management LLC grew its holdings in shares of OrthoPediatrics by 35.1% during the first quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after purchasing an additional 232,760 shares during the last quarter. Finally, AWM Investment Company Inc. acquired a new stake in shares of OrthoPediatrics during the second quarter worth about $4,537,000. 69.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

KIDS has been the topic of a number of recent analyst reports. Truist Financial set a $22.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, August 5th. Needham & Company LLC lifted their price objective on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Weiss Ratings raised OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 5th. BTIG Research raised their price target on OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, August 20th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $26.44.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.